HR 63 · 110th Congress 2007โ€“2009, ended

RU-486 Suspension and Review Act of 2007

Latest action · Feb 2, 2007 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedJan 4, 2007
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

RU-486 Suspension and Review Act of 2007 - Deems the approved application for the drug mifepristone (marketed as Mifeprex, commonly known as RU-486, and used for the chemically induced termination of intrauterine pregnancy) to have been withdrawn.

Deems the drug misoprostol to be misbranded under the Federal Food, Drug, and Cosmetic Act (FFDCA) if it bears labeling providing that the drug may be used for the medical termination of intrauterine pregnancy.

Directs the Comptroller General to review and report on the process by which the Food and Drug Administration (FDA) approved mifepristone. Provides for the reinstatement of the approved application for such drug if the report determines the approval to have been in accordance with FFDCA.

Cosponsors 48

Members who signed on, in the order they did. Signatures ran from Jan 17, 2007 to May 20, 2008.

SeatCosponsorSigned on
R-IDBill SaliJan 17, 2007
R-GACharles W. NorwoodJan 17, 2007
R-NJChristopher H. SmithJan 17, 2007
R-ILDonald A. ManzulloJan 17, 2007
R-KYGeoff DavisJan 17, 2007
R-NEJeff FortenberryJan 17, 2007
R-VAJo Ann DavisJan 17, 2007
R-SCJoe WilsonJan 17, 2007
D-TNLincoln DavisJan 17, 2007
R-COMarilyn N. MusgraveJan 17, 2007
R-TNMarsha BlackburnJan 17, 2007
R-MIPeter HoekstraJan 17, 2007
R-GAPhil GingreyJan 17, 2007
R-LARodney AlexanderJan 17, 2007
R-MSRoger F. WickerJan 17, 2007

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Jan 4, 2007
Health Subcommittee
Referred Feb 2, 2007

Actions 3

Everything that happened, newest first.

  1. Feb 2, 2007Referred to the Subcommittee on Health.
  2. Jan 4, 2007Introduced in House
  3. Jan 4, 2007Referred to the House Committee on Energy and Commerce.

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug commonly known as RU-486 is deemed to have been withdrawn, to provide for the review by the Comptroller General of the United States of the process by which the Food and Drug Administration approved such drug, and for other purposes.
Short Titles as Introduced
RU-486 Suspension and Review Act of 2007

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Jan 4, 2007Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.